Moreover, EIF4G1 was found to be overexpressed in several solid tumors [29–36], such as hypopharyngeal cancer, cervical carcinoma, breast cancer, multiple myeloma, lung cancer, ovarian cancer, and PCa. This evidence concerns the gene EIF4G1 and posterior cortical atrophy.